Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C334805-5mg | 5mg | In stock | $46.90 | |
C334805-10mg | 10mg | In stock | $72.90 | |
C334805-25mg | 25mg | In stock | $162.90 | |
C334805-50mg | 50mg | In stock | $292.90 | |
C334805-100mg | 100mg | In stock | $526.90 |
a compound that can permeate the cell and act independent of the PPARα
Synonyms | Benzoic acid, 4-(hexadecylamino)- | Cetabenum | 4-(n-Hexadecylamino)benzoic acid | 4-(n-hexadecylamino)-benzoic acid | FT-0603002 | HY-119964 | AKOS032947282 | MS-25733 | SR-01000944982-2 | Cetaben | SR-01000944982-1 | DTL5W0113X | SCHEMBL2112078 | UNII-D |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Note | For preparation of stock solution, dissolve cataben in an organic solvent purged with an inert gas. |
Product Description | Peroxisome Proliferator, Cetaben is a compound that can permeate the cell and act independent of the peroxisome proliferator-activated receptor α (PPARα). In addition, it has been shown to inhibit the activity of acyl-CoA:cholesterol acyltransferase (ACAT). The compound has hypolipidemic activity and research shows that it can reduce serum triglyceride and cholesterol concentrations in rats. It has the ability to inhibit cholesterol production in human hepatoma Hep-G2 cells, which can cause reversible changes to the Golgi morphology. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | 4-(hexadecylamino)benzoic acid |
---|---|
INCHI | InChI=1S/C23H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20-24-22-18-16-21(17-19-22)23(25)26/h16-19,24H,2-15,20H2,1H3,(H,25,26) |
InChi Key | QXWKHSSBFQDQPR-UHFFFAOYSA-N |
Canonical SMILES | CCCCCCCCCCCCCCCCNC1=CC=C(C=C1)C(=O)O |
Isomeric SMILES | CCCCCCCCCCCCCCCCNC1=CC=C(C=C1)C(=O)O |
PubChem CID | 47263 |
Molecular Weight | 361.6 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2308154 | Certificate of Analysis | Dec 01, 2022 | C334805 |
B2308219 | Certificate of Analysis | Dec 01, 2022 | C334805 |
B2308220 | Certificate of Analysis | Dec 01, 2022 | C334805 |
B2308221 | Certificate of Analysis | Dec 01, 2022 | C334805 |
B2308222 | Certificate of Analysis | Dec 01, 2022 | C334805 |
B2308223 | Certificate of Analysis | Dec 01, 2022 | C334805 |
Solubility | In DMSO and then diluted in aqueous buffer. Soluble in 0.15mg/ml in a 1:1 solution of DMSO:PBS (pH 7.2). Do not store solution more then one day. |
---|